OSTEOCHONDRAL DEFECTS
Cartilage Lesions | MACI | OAT | Restoration
ICRS Grade
Critical Must-Knows
- Medial femoral condyle is most common location
- ICRS grading classifies cartilage damage
- Microfracture for small (less than 2cm²) contained lesions
- MACI/ACI for larger lesions (greater than 2-4cm²)
- OAT (mosaicplasty) for small-moderate lesions
Examiner's Pearls
- "Address alignment, meniscal, and ligament issues concurrently
- "Microfracture produces fibrocartilage (Type I collagen)
- "ACI/MACI produces hyaline-like cartilage (Type II)
- "OAT transfers hyaline cartilage with bone from non-weight-bearing area
Clinical Imaging
Imaging Gallery



Clinical Imaging
Imaging Gallery
Critical OCD Knee Exam Points
Microfracture
Small lesions (less than 2cm²). Marrow stimulation. Creates fibrocartilage (Type I collagen). Good short-term but deteriorates at 5+ years. Contained lesion ideal.
MACI/ACI
Larger lesions (greater than 2-4cm²). Two-stage: harvest chondrocytes, culture, implant. MACI uses membrane. Produces hyaline-like cartilage. Better long-term than microfracture for large lesions.
OAT
Osteochondral autograft transfer (mosaicplasty). Small-moderate lesions. Plugs from non-weight-bearing area (trochlea, notch). True hyaline cartilage. Limited by donor site.
OCA
Osteochondral allograft. Large lesions (greater than 4cm²). Fresh allograft. Good for young patients with large defects. Disease transmission risk, availability issues.
At a Glance
Osteochondral defects involve damage to articular cartilage and underlying subchondral bone, with the medial femoral condyle (MFC) being the most common weight-bearing location. Treatment selection is size-dependent: microfracture for small lesions (less than 2cm²) produces fibrocartilage (Type I collagen), while MACI/ACI for larger lesions (greater than 2-4cm²) produces hyaline-like cartilage (Type II). OAT (mosaicplasty) transfers true hyaline cartilage with bone from non-weight-bearing areas. Critical principle: always address concomitant alignment, meniscal, and ligamentous pathology for successful outcomes.
SIZETreatment Selection by Size
Memory Hook:SIZE determines treatment: Small = microfracture/OAT, Large = MACI/OCA!
Overview and Classification
Osteochondral defects of the knee involve damage to the articular cartilage and potentially underlying subchondral bone. Goals of treatment are pain relief, improved function, and prevention of osteoarthritis.
ICRS Classification
Grade I: Superficial softening, fibrillation Grade II: Partial thickness lesion (less than 50% depth) Grade III: Deep lesion (greater than 50% depth) or down to subchondral bone Grade IV: Full thickness with exposed subchondral bone
Grade III and IV are generally treated.
Location
Medial femoral condyle (MFC): Most common weight-bearing location for symptomatic lesions.
Treatment Options

Mechanism: Create holes in subchondral bone. Marrow elements (MSCs, blood) fill defect. Forms fibrocartilage.
Indications: Small lesions (less than 2cm², ideally less than 1.5cm²). Contained with healthy shoulder. First-line for small lesions.
Technique: Debride edges to stable margins. Create microfracture holes 3-4mm apart, 3-4mm deep.
Outcomes: Good short-term (2-5 years). Deteriorates over time. Fibrocartilage (Type I collagen) less durable than hyaline (Type II).
Key Considerations
Address Concurrent Pathology
Alignment: Varus/valgus malalignment must be corrected (HTO, DFO). Uncorrected alignment leads to failure.
Meniscus: Meniscal deficiency increases contact stress. Consider MAT if previous meniscectomy.
Ligaments: ACL deficiency causes abnormal kinematics. Reconstruct if unstable.
Patient Selection
- Young (typically under 40-50)
- Active, motivated
- Single compartment disease
- Focal lesion (not diffuse OA)
- Normal or correctable alignment
- Stable knee
Evidence Base
- MACI vs microfracture for knee cartilage defects
- MACI superior at 5 years
- Better cartilage repair tissue with MACI
- MACI recommended for larger lesions
- Microfracture systematic review
- Good short-term results
- Deterioration at 5+ years
- Lesion size matters
Exam Viva Scenarios
Practice these scenarios to excel in your viva examination
Scenario 1: Cartilage Defect Treatment
"A 28-year-old has a 3cm² full-thickness cartilage defect on the medial femoral condyle. Knee is stable with normal alignment. What are your treatment options?"
Scenario 2: Failed Microfracture - Revision Decision-Making
"You are seeing a 32-year-old recreational footballer in your clinic 3 years after he underwent arthroscopic microfracture for a 1.8cm² ICRS grade IV cartilage defect on the medial femoral condyle. At the time, microfracture was appropriate given the lesion size (under 2cm²) and he was a suitable candidate - young, active, stable knee with normal alignment. He did well initially, returning to football at 9 months post-operatively with significant improvement in his knee pain. However, over the past 6-8 months, his medial knee pain has gradually returned and is now limiting his ability to play football. He has tried physiotherapy, activity modification, and NSAIDs with minimal benefit. On examination, he has medial joint line tenderness, a small effusion, and pain with deep knee flexion. Range of motion is full (0-135°). His knee is stable to ligamentous examination and there is no malalignment on standing alignment. You order an MRI which shows deterioration of the previously treated cartilage lesion - the microfractured area now has poor fill with irregular surface and underlying bone marrow edema. The lesion measures approximately 2.2cm² (slightly larger than original). There is no evidence of other cartilage damage, meniscal pathology, or ligamentous injury. The patient is frustrated and asks what can be done - he wants to continue playing football. How do you counsel him and what is your management plan?"
Scenario 3: Large Cartilage Defect with Multiple Concurrent Pathologies - Complex Staged Reconstruction
"You are seeing a 35-year-old woman in your knee reconstruction clinic who was referred by a colleague. She has severe medial knee pain following a skiing injury 4 years ago where she sustained an ACL rupture which was reconstructed at the time. However, her pain has progressively worsened despite a stable ACL reconstruction. She has tried conservative management including physiotherapy, weight loss (BMI now 28, down from 32), activity modification, and multiple courses of injections with minimal sustained benefit. She is now unable to walk more than 500 meters without severe pain and has had to stop her active lifestyle completely. On examination, she has marked medial joint line tenderness, moderate effusion, full range of motion (0-130°), stable ACL reconstruction (negative Lachman and pivot shift), but varus thrust during gait. Standing alignment films show 6° of mechanical varus with the mechanical axis passing well medial to the knee center, loading the medial compartment. MRI shows a large ICRS grade IV cartilage defect on the medial femoral condyle measuring 5cm² with significant bone marrow edema. Additionally, the MRI shows that she had a previous total medial meniscectomy (you review the notes - at the time of her ACL reconstruction 4 years ago, the medial meniscus was found to be complex and degenerative with extensive tearing, and the surgeon performed a total meniscectomy). There is no evidence of significant arthritis in other compartments - the lateral compartment is pristine. The patient is desperate for help and wants to avoid knee replacement as long as possible. A previous surgeon told her nothing could be done and she would need a knee replacement within 5 years. How do you counsel her and what is your surgical plan if you proceed?"
MCQ Practice Points
Exam Pearl
Q: What lesion size thresholds guide treatment selection for osteochondral defects?
A: Less than 2 cm²: Microfracture or drilling preferred. 2-4 cm²: OATS (osteochondral autograft) or ACI (autologous chondrocyte implantation). Greater than 4 cm²: ACI or osteochondral allograft (fresh). Microfracture produces fibrocartilage (Type I collagen), while ACI/OATS produce hyaline-like cartilage (Type II collagen).
Exam Pearl
Q: What is the ICRS classification for cartilage lesions?
A: Grade 0: Normal. Grade 1: Superficial lesions (soft, fissures). Grade 2: Less than 50% depth. Grade 3: Greater than 50% depth, not reaching subchondral bone. Grade 4: Full thickness with exposed subchondral bone. Guides treatment: Grade 3-4 lesions with symptoms are candidates for cartilage restoration procedures.
Exam Pearl
Q: What are the advantages and disadvantages of OATS versus ACI?
A: OATS advantages: Single-stage, immediate hyaline cartilage, structural bone support. OATS disadvantages: Donor site morbidity, limited graft availability, plug mismatch. ACI advantages: Larger lesions, no donor morbidity. ACI disadvantages: Two-stage, requires periosteal flap or collagen membrane, expensive.
Exam Pearl
Q: What MRI findings indicate an unstable osteochondritis dissecans lesion?
A: Unstable OCD signs: High T2 signal rim surrounding fragment (fluid interface), cystic changes in subchondral bone, breach of articular cartilage, loose body formation. Unstable lesions require surgical fixation or fragment removal. Stable lesions may be treated nonoperatively in skeletally immature patients.
Exam Pearl
Q: What is the preferred harvest site for OATS in the knee?
A: Lateral femoral trochlea (superolateral, above sulcus terminalis) and intercondylar notch. These areas are non-weight-bearing. Harvest plugs perpendicular to surface. Maximum 2-3 plugs to avoid significant donor morbidity. Plug diameter typically 6-10mm. Match recipient site curvature.
Australian Context
Australian Epidemiology and Practice
Osteochondral Lesion Epidemiology in Australia:
- Osteochondral defects of the knee represent a significant cause of knee pain and dysfunction in the Australian population
- High sporting participation rates contribute to increased incidence of traumatic osteochondral injuries
- AFL, rugby, and football-related knee injuries frequently involve chondral or osteochondral damage
- Increasing awareness has led to earlier diagnosis and referral for cartilage restoration procedures
RACS Orthopaedic Training Relevance:
- Osteochondral defects are a core topic in the FRACS Orthopaedic examination syllabus
- Viva scenarios commonly test understanding of classification systems (ICRS, Outerbridge), diagnostic approach, and treatment algorithms
- Key examination focus: indications for microfracture vs OAT vs ACI/MACI, size thresholds for treatment selection
- Candidates should understand the principles of malalignment correction and meniscal pathology that affect treatment outcomes
Australian Cartilage Restoration Practice:
- Microfracture remains widely used for smaller lesions (less than 2cm²) in primary treatment settings
- Osteochondral autograft transfer (OAT/mosaicplasty) performed for contained lesions 1-4cm² with good outcomes
- Matrix-induced autologous chondrocyte implantation (MACI) available through specialised centres for larger defects
- TGA-approved MACI products are accessible in Australia for appropriate candidates
- Subspecialty knee surgeons in major metropolitan centres typically manage complex cartilage restoration cases
AOANJRR Considerations:
- The Australian Orthopaedic Association National Joint Replacement Registry tracks long-term outcomes of knee procedures
- Patients with prior cartilage procedures who progress to arthroplasty are captured in registry data
- Registry data informs understanding of cartilage restoration failure rates and subsequent management
Rehabilitation and Recovery:
- Australian physiotherapy protocols align with international standards for post-cartilage restoration rehabilitation
- Protected weight-bearing and graduated return to activity are essential components
- Sports medicine physicians and physiotherapists play key roles in the multidisciplinary team
OSTEOCHONDRAL DEFECTS
High-Yield Exam Summary
Treatment by Size
- •Small (less than 2cm²): Microfracture, OAT
- •Medium (2-4cm²): OAT, MACI
- •Large (greater than 4cm²): MACI, OCA
Cartilage Quality
- •Microfracture: Fibrocartilage (Type I)
- •MACI/ACI: Hyaline-like (Type II)
- •OAT/OCA: True hyaline with bone
Address Concurrent
- •Malalignment (HTO/DFO)
- •Meniscal deficiency (MAT)
- •ACL instability (ACLR)
MACI
- •Two-stage procedure
- •Larger lesions (greater than 2cm²)
- •Better than microfracture long-term
- •Hyaline-like cartilage